vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Pony AI Inc. (PONY). Click either name above to swap in a different company.

Pony AI Inc. is the larger business by last-quarter revenue ($2.1M vs $1.8M, roughly 1.2× INVO Fertility, Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -284.8%, a 134.2% gap on every dollar of revenue.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Pony Canyon Inc. , also known by the shorthand form Ponican , is a Japanese company, established on October 1, 1966, which distributes music, films, home video, and video games. It is affiliated with the Japanese media group Fujisankei Communications Group. Pony Canyon is a major leader in the music industry in Japan, with its artists regularly at the top of the Japanese charts. Pony Canyon is also responsible for releasing taped concerts from its artists as well as many anime productions and...

IVF vs PONY — Head-to-Head

Bigger by revenue
PONY
PONY
1.2× larger
PONY
$2.1M
$1.8M
IVF
Higher net margin
IVF
IVF
134.2% more per $
IVF
-150.5%
-284.8%
PONY

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
IVF
IVF
PONY
PONY
Revenue
$1.8M
$2.1M
Net Profit
$-2.6M
$-5.9M
Gross Margin
9.2%
Operating Margin
-93.1%
-275.3%
Net Margin
-150.5%
-284.8%
Revenue YoY
22.6%
Net Profit YoY
-62.2%
EPS (diluted)
$-0.77
$-3.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
PONY
PONY
Q3 25
$1.8M
$2.1M
Q2 25
$1.9M
$1.7M
Q1 25
$1.6M
$1.9M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$1.8M
Q1 24
$1.6M
Q4 23
$1.4M
Net Profit
IVF
IVF
PONY
PONY
Q3 25
$-2.6M
$-5.9M
Q2 25
$-5.3M
$-4.3M
Q1 25
$-17.4M
$-5.2M
Q4 24
$-3.6M
Q3 24
$-1.6M
Q2 24
$-2.2M
Q1 24
$-1.6M
Q4 23
$-2.0M
Gross Margin
IVF
IVF
PONY
PONY
Q3 25
9.2%
Q2 25
Q1 25
35.2%
16.6%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Q4 23
33.0%
Operating Margin
IVF
IVF
PONY
PONY
Q3 25
-93.1%
-275.3%
Q2 25
-160.4%
-303.4%
Q1 25
-1042.1%
-400.9%
Q4 24
-202.0%
Q3 24
-90.7%
Q2 24
-100.9%
Q1 24
-95.7%
Q4 23
-109.2%
Net Margin
IVF
IVF
PONY
PONY
Q3 25
-150.5%
-284.8%
Q2 25
-283.6%
-253.7%
Q1 25
-1060.1%
-267.4%
Q4 24
-211.3%
Q3 24
-113.8%
Q2 24
-122.2%
Q1 24
-101.3%
Q4 23
-144.4%
EPS (diluted)
IVF
IVF
PONY
PONY
Q3 25
$-0.77
$-3.51
Q2 25
$-13.30
$-0.92
Q1 25
$-12.53
$-0.12
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55
Q4 23
$-59.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
PONY
PONY
Cash + ST InvestmentsLiquidity on hand
$62.5M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$114.1M
Total Assets
$18.8M
$126.5M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
PONY
PONY
Q3 25
$62.5M
Q2 25
$84.9M
Q1 25
$86.8M
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Total Debt
IVF
IVF
PONY
PONY
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
IVF
IVF
PONY
PONY
Q3 25
$5.8M
$114.1M
Q2 25
$2.6M
$120.6M
Q1 25
$3.3M
$126.4M
Q4 24
$12.7M
Q3 24
$-23.3K
Q2 24
$1.4M
Q1 24
$10.2K
Q4 23
$892.8K
Total Assets
IVF
IVF
PONY
PONY
Q3 25
$18.8M
$126.5M
Q2 25
$19.3M
$138.3M
Q1 25
$31.7M
$134.0M
Q4 24
$46.4M
Q3 24
$17.0M
Q2 24
$17.8M
Q1 24
$17.3M
Q4 23
$18.5M
Debt / Equity
IVF
IVF
PONY
PONY
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
PONY
PONY
Operating Cash FlowLast quarter
$-1.8M
$-2.9M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
PONY
PONY
Q3 25
$-1.8M
$-2.9M
Q2 25
$-1.7M
$-2.5M
Q1 25
$-3.5M
$-7.5M
Q4 24
$-617.4K
Q3 24
$-640.8K
Q2 24
$-1.5M
Q1 24
$-260.6K
Q4 23
$-714.9K
Free Cash Flow
IVF
IVF
PONY
PONY
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
Q4 23
FCF Margin
IVF
IVF
PONY
PONY
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Q4 23
Capex Intensity
IVF
IVF
PONY
PONY
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons